KAIROS PHARMA LTD (KAPA) Stock News

NYSEARCA:KAPA - US48301N1046 - Common Stock

1.18 USD

+0.01 (+0.85%)

Last: 8/22/2025, 8:19:54 PM

1.17 USD

-0.01 (-0.85%)

After Hours: 8/22/2025, 8:19:54 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

KAPA Latest News, Press Relases and Analysis

All

Press Releases

24 days ago - By: Benzinga - Mentions: ALGN DYAI MDXG HCTI ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

a month ago - By: Benzinga - Mentions: HBIO SRPT MEIP WINT ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session

a month ago - By: Kairos Pharma, Ltd

Kairos Pharma Announces Participation and Presentation in the H.C. Wainwright 27th Annual Global Investment Conference September 8-10, 2025

a month ago - By: Kairos Pharma, Ltd

Kairos Pharma Announces Positive Safety Results from Phase 2 Trial of ENV-105 in Advanced Prostate Cancer

3 months ago - By: Kairos Pharma, Ltd

Kairos Pharma Ltd. Announces New Data on Small Molecule GITR Ligand Agonist KROS 101 as Promising Cancer Immunotherapy at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting

4 months ago - By: Kairos Pharma, Ltd

Kairos Pharma, Ltd. Announces Data to be Presented at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting

4 months ago - By: Kairos Pharma, Ltd

Kairos Pharma Ltd. Provides Letter to Stockholders

4 months ago - By: Kairos Pharma, Ltd

Kairos Pharma Ltd. Announces Department of Defense Grant to Support Its Study of Lead Compound ENV105 to Prevent Drug Resistance in Lung Cancer